Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Prepaid Assets (2016 - 2025)

Seres Therapeutics' Prepaid Assets history spans 11 years, with the latest figure at $3.1 million for Q3 2025.

  • For Q3 2025, Prepaid Assets fell 49.02% year-over-year to $3.1 million; the TTM value through Sep 2025 reached $3.1 million, down 49.02%, while the annual FY2024 figure was $5.8 million, 27.78% down from the prior year.
  • Prepaid Assets for Q3 2025 was $3.1 million at Seres Therapeutics, up from $2.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $15.2 million in Q1 2022 and bottomed at $2.4 million in Q2 2025.
  • The 5-year median for Prepaid Assets is $8.8 million (2021), against an average of $8.6 million.
  • The largest annual shift saw Prepaid Assets surged 131.96% in 2022 before it crashed 62.33% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $12.9 million in 2021, then increased by 3.88% to $13.4 million in 2022, then tumbled by 40.04% to $8.0 million in 2023, then dropped by 27.78% to $5.8 million in 2024, then tumbled by 46.46% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for MCRB's Prepaid Assets are $3.1 million (Q3 2025), $2.4 million (Q2 2025), and $4.5 million (Q1 2025).